Synthesis and Photodynamic Activity of Peri-xanthenoxanthene Derivatives

Chem Pharm Bull (Tokyo). 2019 Jul 1;67(7):690-692. doi: 10.1248/cpb.c19-00240. Epub 2019 Apr 20.

Abstract

Photodynamic therapy (PDT) is a modern cancer therapy. But it is still difficult to obtain ideal photosensitizers. We synthesized six new peri-xanthenoxanthene derivatives rapidly and efficiently using solid-phase carbon-bath microwave irradiation technology, and investigated their in vitro photodynamic antitumor activity with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Our results showed that all compounds exhibited extremely low dark cytotoxicity and good phototoxicity against four human cancer cell lines. In particular, compound 3c showed the best in vitro PDT activity against Hela cells and Bel-7402 cells with IC50 values of 91 and 74 nmol/L, respectively. Its value of 1-octanol/water partition coefficient (log Kow) was 0.5309, suggesting that it is a promising photosensitizer for PDT due to its low dark cytotoxicity, high phototoxicity, and potential water solubility.

Keywords: 1-octanol–water partition; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay; antitumor; peri-xanthenoxanthene; photodynamic therapy (PDT).

MeSH terms

  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Screening Assays, Antitumor
  • HeLa Cells
  • Humans
  • Inhibitory Concentration 50
  • Microwaves
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Photochemotherapy
  • Photosensitizing Agents / chemical synthesis*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Xanthenes / chemistry*
  • Xanthenes / pharmacology
  • Xanthenes / therapeutic use

Substances

  • Photosensitizing Agents
  • Reactive Oxygen Species
  • Xanthenes